Regeneron Pharmaceuticals Statistics
Total Valuation
REGN has a market cap or net worth of $74.45 billion. The enterprise value is $58.56 billion.
| Market Cap | 74.45B |
| Enterprise Value | 58.56B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026, before market open.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Feb 20, 2026 |
Share Statistics
REGN has 101.74 million shares outstanding. The number of shares has decreased by -5.65% in one year.
| Current Share Class | 99.92M |
| Shares Outstanding | 101.74M |
| Shares Change (YoY) | -5.65% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 3.83% |
| Owned by Institutions (%) | 89.49% |
| Float | 97.67M |
Valuation Ratios
The trailing PE ratio is 17.64 and the forward PE ratio is 16.18. REGN's PEG ratio is 1.56.
| PE Ratio | 17.64 |
| Forward PE | 16.18 |
| PS Ratio | 5.19 |
| Forward PS | 4.63 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | 18.25 |
| P/OCF Ratio | 14.95 |
| PEG Ratio | 1.56 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.79, with an EV/FCF ratio of 14.35.
| EV / Earnings | 13.00 |
| EV / Sales | 4.08 |
| EV / EBITDA | 13.79 |
| EV / EBIT | 15.82 |
| EV / FCF | 14.35 |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.13 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 0.73 |
| Interest Coverage | 84.52 |
Financial Efficiency
Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.54%.
| Return on Equity (ROE) | 14.87% |
| Return on Assets (ROA) | 5.91% |
| Return on Invested Capital (ROIC) | 12.54% |
| Return on Capital Employed (ROCE) | 10.23% |
| Weighted Average Cost of Capital (WACC) | 6.23% |
| Revenue Per Employee | $930,753 |
| Profits Per Employee | $292,336 |
| Employee Count | 15,410 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.53 |
Taxes
In the past 12 months, REGN has paid $725.80 million in taxes.
| Income Tax | 725.80M |
| Effective Tax Rate | 13.88% |
Stock Price Statistics
The stock price has increased by +21.43% in the last 52 weeks. The beta is 0.40, so REGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +21.43% |
| 50-Day Moving Average | 761.06 |
| 200-Day Moving Average | 681.50 |
| Relative Strength Index (RSI) | 40.75 |
| Average Volume (20 Days) | 663,461 |
Short Selling Information
The latest short interest is 2.84 million, so 2.79% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short Previous Month | 2.55M |
| Short % of Shares Out | 2.79% |
| Short % of Float | 2.91% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, REGN had revenue of $14.34 billion and earned $4.50 billion in profits. Earnings per share was $41.48.
| Revenue | 14.34B |
| Gross Profit | 6.39B |
| Operating Income | 3.70B |
| Pretax Income | 5.23B |
| Net Income | 4.50B |
| EBITDA | 4.25B |
| EBIT | 3.70B |
| Earnings Per Share (EPS) | $41.48 |
Balance Sheet
The company has $8.61 billion in cash and $2.97 billion in debt, giving a net cash position of $15.89 billion or $156.21 per share.
| Cash & Cash Equivalents | 8.61B |
| Total Debt | 2.97B |
| Net Cash | 15.89B |
| Net Cash Per Share | $156.21 |
| Equity (Book Value) | 31.26B |
| Book Value Per Share | 304.65 |
| Working Capital | 13.65B |
Cash Flow
In the last 12 months, operating cash flow was $4.98 billion and capital expenditures -$898.40 million, giving a free cash flow of $4.08 billion.
| Operating Cash Flow | 4.98B |
| Capital Expenditures | -898.40M |
| Depreciation & Amortization | 543.70M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.08B |
| FCF Per Share | $40.11 |
Margins
Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.
| Gross Margin | 44.57% |
| Operating Margin | 25.81% |
| Pretax Margin | 36.47% |
| Profit Margin | 31.41% |
| EBITDA Margin | 29.60% |
| EBIT Margin | 25.81% |
| FCF Margin | 28.45% |
Dividends & Yields
This stock pays an annual dividend of $3.76, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | $3.76 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 8.63% |
| Buyback Yield | 5.65% |
| Shareholder Yield | 6.16% |
| Earnings Yield | 6.05% |
| FCF Yield | 5.48% |
Analyst Forecast
The average price target for REGN is $832.85, which is 13.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $832.85 |
| Price Target Difference | 13.81% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 5.38% |
| EPS Growth Forecast (5Y) | 8.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
REGN has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.51 |
| Piotroski F-Score | 4 |